Press room

News

Pit3D, recognized as Best Business Project at Café Aventura 2025
Pit3D, recognized as Best Business Project at Café Aventura 2025 1080 608 Oriol Capell

The jury highlighted its innovative approach and its potential impact on the quality of life of women who have undergone a mastectomy.

read more
The Creu Alta School of Music raises funds for I3PT research
The Creu Alta School of Music raises funds for I3PT research 1080 608 Oriol Capell

All the money raised in the traditional charity concert in Santa Cecília will go towards the Institute's research.

read more
I3PT receives a grant from La Marató to develop an innovative treatment against pneumonia
I3PT receives a grant from La Marató to develop an innovative treatment against pneumonia 1080 608 Mireia Córcoles

The research team proposes a new therapeutic strategy for the treatment and recovery of pneumonia, a disease that causes 2,2 million deaths annually

read more
The SYNERGY project is born to investigate the genetic connection between two inflammatory diseases
The SYNERGY project is born to investigate the genetic connection between two inflammatory diseases 1080 608 Oriol Capell

The study led by Parc Taulí-I3PT will delve deeper into the relationship between hidradenitis suppurativa and spondyloarthritis using targeted sequencing techniques

read more

Press releases

2025

An I3PT study opens the door to curing early-stage rectal cancer while preserving the organ

June 27, 2025. The research, published in 'JAMA Surgery', demonstrates that it is not necessary to remove the rectum in early stages of the disease with the same oncological efficacy as complete surgery, applying chemo-radiotherapy treatment and minimal surgery.

A project for research into Prader-Willi syndrome, winner of the Pau Massana Grant

April 11, 2025. The study addresses Prader-Willi syndrome from a dual perspective, combining two complementary lines of research to improve knowledge and treatment of the disease, for which no cure has currently been found.

An international study reveals serious shortcomings in sepsis care in hospitals

February 5, 2025. A study published in the American Journal of Respiratory and Critical Care Medicine, in collaboration with I3PT, highlights critical gaps in the detection and management of sepsis in European hospitals

The Ethics and Drug Research Committee of Parc Taulí leads the evaluation of clinical trials in Catalonia

February 3, 2025. The CEIm of Parc Taulí is consolidated as the first in Catalonia and the third in Spain in the evaluation of clinical trials, according to the ranking prepared annually by the AEMPS

2024

Tesai Care launches a pioneering clinical trial with heecap to prevent respiratory muscle atrophy in mechanically ventilated patients

December 9, 2024. This is a unique treatment strategy in the healthcare field, based on non-invasive electrical stimulation to maintain the strength of the respiratory muscles of patients in need of mechanical ventilation support.

The LIFE GENESYS project will develop a pioneering purification system to remove antibiotics and resistant bacteria from hospital effluents

September 25, 2024. The European project team will design and implement at the Parc Taulí University Hospital an innovative and unique wastewater treatment system in Spain

Clinical trial begins for AI software to detect lung cancer in unanalyzed X-rays

Jul 25, 2024. Dubbed Optimal XR, this tool aims to prevent potentially malignant lung nodules that are currently not diagnosed in time from continuing to go unnoticed.

A project for the research of Angelman syndrome, winner of the Pau Massana Grant

9 May 2024. The study, led by researchers Marta Moraleda and Débora Itzep, will investigate sleep and circadian rhythm disorders in children and adolescents with this pathology.

Not doing a specific diet to prepare for a colonoscopy has no implications for the test

April 24, 2024. A study led by the I3PT finds that not following a restrictive diet does not affect quality or efficiency parameters, and improves tolerability and patient satisfaction.

CONNECTA Therapeutics, CRG, IMIM and I3PT receive 2,7 million euros from the Ministry of Science and Innovation to start Phase IIa of the drug CTH120 for fragile X syndrome

February 12, 2024. The Phase IIa study will evaluate the effectiveness of CTH120 as a breakthrough therapy in adult patients with SXF, the most common form of inherited intellectual disability without a specific treatment.

2023

A study of the Spanish population shows that nearly 795.000 children have allergies, and 397.000, asthma

8 June 2023. 5% of children under the age of 7 in Spain have asthma, and 14% have allergies, mainly allergic rhinitis.

The I3PT receives accreditation from the Ministry as a Health Research Institute

March 20, 2023. The Institute has received this recognition of excellence from the Ministerio de Ciencia e Innovación, after successfully passing the audit process of the Instituto de Salud Carlos III.

Eodyne Systems and I3PT create virtual reality device to reduce patient recovery time in ICUs

January 18, 2023. The Secretary of Business and Competitiveness and CEO of ACCIÓ, Albert Castellanos, visited this morning the Parc Taulí University Hospital in Sabadell, where the company has carried out a pilot test of the technology.

The Parc Taulí and the Hospital Clínic, a step forward in the leadership of the clinical application of 3D

January 4, 2023. The Parc Taulí Research and Innovation Institute (I3PT) and the Hospital Clínic sign a collaboration agreement to develop innovation projects using 3D technology

2022

A study reveals the equal effectiveness of iodine and chlorhexidine in fracture surgeries

November 3, 2022. The I3PT has participated in the largest international study to date to compare antiseptic skin solutions and decrease infection in open fracture surgery. The results have been published in the journal 'The Lancet'

They detect a biomarker that identifies vascular aging in patients with diabetes

September 23, 2022. Researchers from the I3PT, the IMIM-Hospital del Mar and the IISPV describe a biomarker in the blood of patients with type 1 diabetes that makes it possible to identify the degree of early vascular aging associated with the risk of complications in various organs

The I3PT creates Tailorsurgery, a spin-off dedicated to the application of 3D printing in traumatology

September 8, 2022. The consolidation of the Parc Taulí 3D Laboratory as its own space for the design and manufacture of customized instruments and implants allows the establishment of this platform that will market its services on a global scale

New therapy to avoid chemotherapy in lung cancer

July 25, 2022 Study results show efficacy of new treatment combining two immunotherapy drugs in patients with metastatic lung cancer

An innovative treatment for rectal cancer improves morbidity and prevents permanent sequelae

June 27, 2022. The current results of the study are very hopeful and pave the way to making a change in surgical strategy in the treatment of these tumors, which would involve performing a local chemo-radiotherapy treatment and a minimal local surgery, preserving the rectum

Parc Taulí and Aigües Sabadell will study the presence of antibiotic-resistant genes and bacteria in the city's wastewater

April 1, 2022. The initiative is part of the community health axis of the Biotop project, promoted by the City Council and the water company

I3PT founds ANAIS Medical to bring high-realism medical simulation for interventional procedures closer to professionals

January 17, 2022. ANAIS Medical is the new spin-off of the Institute that was born with the aim of developing practical educational material, through realistic models and simulators, to train and improve the skills of clinical experts in interventional processes

Protein analysis of a COVID patient can predict its evolution

December 20, 2021. The scientific discovery of I3PT is part of the pioneering study published by the journal Scientific Reports, which shows that with a blood test at the time of admission of a patient with bilateral pneumonia its evolution can be anticipated

2021

People with schizophrenia who participate in clinical trials may not be representative of the population suffering from this disease.

February 9, 2022. People with schizophrenia who participate in clinical trials may not be representative of the population that suffers from this disease.

Resource materials

Dossier of press

Bank of images

Manual of corporate identity and logos

Corporate identity manual

See page 24

Download the logos

Social Networks

Press contact

I watched Córcoles Canet - Communication Manager

93 723 10 10 | Extension: 82214

comunicacioi3pt@tauli.cat

Plaça Torre de l'Aigua, s/n
08208 Sabadell

Oriol Capell Degree – Scientific Communication

93 723 10 10 | Extension: 23102

comunicacioi3pt@tauli.cat

Plaça Torre de l'Aigua, s/n
08208 Sabadell

Privacy preferences

When you visit our website, your browser may store information about specific services, usually in the form of cookies. Here you can change your privacy preferences. Please note that blocking certain types of cookies may affect your experience on our website and the services we offer.

Enable / disable Google Analytics tracking code
Enable / disable Google Fonts
Turn Google Maps on / off
Enable / disable embedded videos
This website uses cookies, mainly from third party services. You can edit your privacy preferences and / or accept the use of cookies.